FDA advisory committee considers risk of heart inflammation from Moderna’s COVID-19 vaccine
The U.S. Food and Drug Administration’s vaccine advisory committee heard testimony Tuesday that Moderna’s COVID-19 vaccine may carry a higher risk of heart inflammation in young men than the vaccine produced by Pfizer/BioNTech. A panel of outside experts met Tuesday
Read More